STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Clinical trials for STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted pill after lung cancer surgery may keep the disease from coming back
Disease control OngoingThis study looks at whether taking crizotinib after surgery can help people with early-stage ALK-positive lung cancer live longer without the cancer returning. About 166 people who had their lung cancer removed will either take crizotinib or just be watched. The goal is to see if…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Precision radiation boosts tumor attack in advanced lung cancer trial
Disease control OngoingThis study tests whether giving a higher radiation dose directly to the tumor, while keeping the dose to nearby healthy organs standard, is safe and effective for people with stage II to III non-small cell lung cancer. It uses advanced imaging to guide either photon (IMRT) or pro…
Matched conditions: STAGE IIIA NON-SMALL CELL LUNG CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC